Phenotypes of asthma in women of childbearing age


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The ways for the development of severe asthma in young people cannot be considered to have been fully studied at present. Objective: to analyze the etlopathogenetlc features and nature of asthma during pregnancy In 2440 asthmatic women of childbearing age. Subjects and methods. A clinical and functional examination and follow-up were performed In 2440 pregnant asthmatic women of childbearing age. Results The allergic mechanism for asthma development prevailed in women of childbearing age. With the addition of an aspirin mechanism and in the presence of a purely aspirin mechanism, the severity of the disease Increased substantially. Chronic polypous rhinosinusltis was an additional aggravating factor for asthma. The highest average number of eosinophilic leukocytes was determined In the group of patients with an aspirin mechanism. The greatest increase In Immunoglobulin E levels was seen In the group with an allergic mechanism of the disease. The analysis of the nature of complications of pregnancy, childbirth, and the status of newborns revealed no features In patients with the mechanism of aspirin-induced asthma. Conclusion. The treatment of patients with asthma, especially with Its severe course, should be performed, by taking Into account the mechanisms of this disease and Include targeted therapy drugs.

全文:

受限制的访问

作者简介

O. Lavrova

First Saint Petersburg State Medical University

Email: loverova@bk.ru

M. Petrova

First Saint Petersburg State Medical University

L. Georgieva

First Saint Petersburg State Medical University

参考

  1. Rachemann F.M. A clinical classification of Asthma based on a review of 648 cases. Am J Med Sci. 1921; 162: 802-12.
  2. Global Strategy For Asthma Management And Prevention Nhlbi/Who Workshop Report (Based on a March 1993 Meeting) National Institutes Of Health National Heart, Lung, and Blood Institute Publication Number 95-3659 January 1995. Documents available from: www.ginasthma.org
  3. Федосеев Г.Б., Хлопотова Г.П. Бронхиальная астма: монография. Л.: Медицина, 1988; с. 15-7 @@Fedoseev G.B., Khlopotova G.P. Bronkhlal’naya astma: monograflya. L.: Meditsina, 1988; s. 15-7 (in Russ.).
  4. Lommatzsch M. et al. Severe Asthma: Definition, Diagnosis and Treatment. Dtsch Arztebl Int. 2014; 111 (50): 847-55. D01:10.3238/arztebl.2014.0847
  5. Niespodziana K., Borochova K., Pazderova P. et al. Toward personalization of asthma treatment according to trigger factors. J Allergy Clin Immunol. 2020; 145 (6): 1529-34. doi: 10.1016/j.jaci.2020.02.001
  6. Федеральные клинические рекомендации по диагностике и лечению бронхиальной астмы (2019) @@Federal’nye klinicheskie rekomendatsii ро diagnostike i lecheniyu bronkhial’noi astmy (2019) (in Russ.). URL: httpsJ/spulmo.ru/
  7. McGregor M.CL, «rings J.G., Nair P. et al. Role of Biologies in Asthma. Review. Am J Respir Crtt Care Med. 2019; 199 (4): 433-45. doi: 10.1164/rccm.201810-1944CI
  8. Scow D.T., Luttermoser G.K., Dickerson K.S. Leucotriene Inhibitors in the treatment of Allergy and Asthma. Am Fam Physician. 2007; 75 (1): 65-70.
  9. Ненашева H.M. Т2-бронхиальная астма: характеристика эндотипа и биомаркеры. Пульмонология. 2019; 29 (2): 216-28 @@Nenasheva N.M. T2-high and T2-low bronchial asthma, endotype characteristics and biomarkers. Pulmonologlya. 2019; 29 (2): 216-28 (in Russ.). doi: 10.18093/0869-0189-2019-29-2-216-228
  10. Bousquet J., Mantzouranis E., Cruz A.A. et al. Uniformdefinition of asthma severity, control, and exacerbations:document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol. 2010; 126 (5): 926-38. doi: 10.1016/j.jaci.2010.07.019.8
  11. Namazy J.A., Schatz M. Management of Asthma during Pregnancy: Optimizing Outcomes and Minimizing Risk. Semin Respir Crlt Care Med. 2018; 39 (1): 29-35. doi: 10.1055/S-0037-1606216

补充文件

附件文件
动作
1. JATS XML

版权所有 © Russkiy Vrach Publishing House, 2021
##common.cookie##